Doxylamine succinate

Specifications

209-228-7EC Number

butanedioic acid;N,N-dimethyl-2-(1-phenyl-1-pyridin-2-ylethoxy)ethanamineIUPAC Name

C21H28N2O5Chemical Formula

388.5 g/molMolecular Weight

Doxylamine succinate; 562-10-7; Decapryn; Gittalun; Unisom; Hoggar N; Doxy-sleep-aid; A-H Injection; Donormil; Mereprine; Sedaplus; Doxylamine succinate (1:1); Alsodorm; Donormyl; Dormidina; Meraprina; Decapryn succinate (1:1); Topcare sleep aid; DTXSID7020552; V9BI9B5YI2; NSC-74772; Dimethylaminoethoxy-methyl-benzyl-pyridine succinate; Doxylamine succinate (USP); Doxylamine succinate [USP]; 2-Dimethylaminoethoxyphenylmethyl-2-picoline succinate; DTXCID10552; 2-(alpha-(2-Dimethylaminoethoxy)-alpha-methylbenzyl)pyridine succinate; NSC74772; Ethanamine, N,N-dimethyl-2-(1-phenyl-1-(2-pyridinyl)ethoxy)-, butanedioate (1:1); BONJESTA COMPONENT DOXYLAMINE SUCCINATE; DICLEGIS COMPONENT DOXYLAMINE SUCCINATE; BENDECTIN COMPONENT DOXYLAMINE SUCCINATE; DICLECTIN COMPONENT DOXYLAMINE SUCCINATE; Pyridine, 2-(alpha-(2-(dimethylamino)ethoxy)-alpha-methylbenzyl)-, succinate (1:1); Sambrosa; Sambrosa Night; sleep aid ultra; ultra sleep aid; Sleep-aid; Unisom Sleeptabs; Sleep Aid; Nocto Sleep Aid; Nighttime Sleep-aid; Nighttime Sleep Aid; Vicks ZzzQuil Ultra; Dg Health Sleep Aid; Basic Care Sleep Aid; Good Sense Sleep Aid; Night Time Sleep Aid; WAL SOM; RefChem:55071; SLEEP AID 25mg; Harris Teeter Sleep Aid; good sense sleep aid ultra; Careone Nighttime Sleep Aid; Sound Body Nighttime Sleep Aid; Up and Up Nighttime Sleep Aid; ZzzQuil ULTRA, Travel BASIX; ZzzQuil ULTRA, Lil Drug Store; Good Neighbor Pharmacy Sleep Aid; A-H-Tablets 100 mg, A-H-Tablets 25 mg; N,N-dimethyl-2-(1-phenyl-1-(2-pyridinyl)ethoxy) ethanamine, butanedioate(1:1); 209-228-7; Butanedioic Acid, compound with N,N-dimethyl-2-(1-phenyl-1-(2-pyridinyl)ethoxy)ethanamine(1:1); Doxylamine (succinate); Doxylamine hydrogen succinate; Evigoa D; Decapryn Succinate; Doxylamine succinate salt; Alsadorm; MFCD00056168; butanedioic acid;N,N-dimethyl-2-(1-phenyl-1-pyridin-2-ylethoxy)ethanamine; MLS000028417; 2-Dimethylaminoethoxyphenylmethyl-2-picoline succinate (1:1); Doxylamine.succinate; SMR000058436; Decapryn (TN); N,N-dimethyl-2-(1-phenyl-1-(pyridin-2-yl)ethoxy)ethanamine succinate; 2-(alpha(2-(Dimethylamino)ethoxy)-alpha-methylbenzyl)pyridine succinate (1:1); CCRIS 4811; SR-01000003036; EINECS 209-228-7; EQUALINE SLEEP AID; NSC 74772; Doxylamine succinate liquid; UNII-V9BI9B5YI2; Safetussin; AI3-23993; 2-[alpha[2-(Dimethylamino)ethoxy]-alpha-methylbenzyl]pyridine succinate (1:1); KBAUFVUYFNWQFM-UHFFFAOYSA-N; NCGC00017028-02; CAS-562-10-7; Prestwick_887; DECAMIUM; Opera_ID_566; Phenyl2-pyridylmethyl-beta-N,N-dimethylaminoethyl ether succinate; alpha-(2-Dimethylaminoethoxy)-alpha-methyl-alpha-phenyl-2-picoline acid succinate; Pyridine, succinate (1:1); MLS000758288; MLS001076141; MLS001424137; MLS002222274; SCHEMBL160443; SPECTRUM1500267; orb1224657; orb1309720; CHEMBL1200392; CHEBI:82461; HMS502K03; Doxylamine hydrogen succinate CRS; DOXYLAMINE SUCCINATE [MI]; HMS1568E15; HMS1920K04; HMS2051F14; HMS2091B09; HMS2095E15; HMS2231G05; HMS3261E17; HMS3370K04; HMS3393F14; HMS3652H19; HMS3712E15; HMS3885D13; HMS5082P16; Pharmakon1600-01500267; DOXYLAMINE SUCCINATE [IARC]; HY-A0069; MSK10896; DOXYLAMINE SUCCINATE [VANDF]; Tox21_113515; Tox21_202078; Tox21_302861; Tox21_500348; CCG-38929; DOXYLAMINE SUCCINATE [MART.]; EBC-84045; N,N-dimethyl-2-(1-phenyl-1-pyridin-2-ylethoxy)ethanamine succinate; NSC756752; s4240; Doxylamine for system suitability CRS; DOXYLAMINE SUCCINATE [USP-RS]; DOXYLAMINE SUCCINATE [WHO-DD]; AKOS025310916; Tox21_113515_1; AC-4487; CCG-101033; CS-3232; FD59815; LP00348; NC00283; NSC-756752; DOXYLAMINE SUCCINATE [GREEN BOOK]; NCGC00016140-02; NCGC00016140-03; NCGC00016140-04; NCGC00021147-11; NCGC00089789-03; NCGC00093785-01; NCGC00093785-02; NCGC00093785-03; NCGC00256517-01; NCGC00259627-01; NCGC00261033-01; AS-13661; DOXYLAMINE SUCCINATE [ORANGE BOOK]; Doxylamine Succinate R&D Working Standard; SY107365; DB-052868; DOXYLAMINE SUCCINATE [USP MONOGRAPH]; D5583; EU-0100348; NS00080013; SW197008-4; T1115; WLN: T6NJ BX1&R&O2N1&1 &OV2VO; C19414; D 3775; D02327; D81886; EN300-123050; DOXYLAMINE HYDROGEN SUCCINATE [EP IMPURITY]; F801726; DOXYLAMINE HYDROGEN SUCCINATE [EP MONOGRAPH]; SR-01000003036-2; SR-01000003036-6; SR-01000003036-9; (Dimethylamino)ethoxy-methyl-benzyl-pyridine succinate; Doxylamine.succinate, 1mg/ml in Methanol (as free base); F2173-1155; [[[(2-Dimethylamino)ethoxy]phenyl]methyl]-2-picoline succinate; Doxylamine Hydrogen Succinate 1.0 mg/ml in Methanol (as free base); Doxylamine succinate, United States Pharmacopeia (USP) Reference Standard; N,N-dimethyl-2-(1-phenyl-1-(pyridin-2-yl)ethoxy)ethan-1-amine succinate; N,N-dimethyl-2-(1-phenyl-1-(pyridin-2-yl)ethoxy)ethanaminesuccinate; N,N-DIMETHYL-2-[1-PHENYL-1-(2-PYRIDINYL)ETHOXY]ETHANAMINE SUCCINATE; N,N-dimethyl-2-[1-phenyl-1-(2-pyridyl)ethoxy]ethanamine;succinic acid; Phenyl2-pyridylmethyl-(.beta.-N,N-dimethylamino)ethyl ether succinate; 2-[[.alpha.-(2-Dimethylamino)ethoxy]-.alpha.-methylbenzyl]pyridine succinate; Butanedioic acid,N-dimethyl-2-[1-phenyl-1-(2-pyridinyl)ethoxy]ethanamine (1:1); Butanedioic acid--N,N-dimethyl-2-[1-phenyl-1-(pyridin-2-yl)ethoxy]ethan-1-amine (1/1); butanedioic acid; dimethyl({2-[1-phenyl-1-(pyridin-2-yl)ethoxy]ethyl})amine; Doxylamine for system suitability, European Pharmacopoeia (EP) Reference Standard; Doxylamine hydrogen succinate, European Pharmacopoeia (EP) Reference Standard; Doxylamine Succinate, Pharmaceutical Secondary Standard; Certified Reference Material; N,N-DIMETHYL-2-((1RS)-1-PHENYL-1-(PYRIDIN-2-YL)ETHOXY(ETHANAMINE HYDROGEN BUTANEDIOATE; Succinate de doxylamineSynonyms